Back to mobile site
Get it on Google Play

PolyPid receives $4.3 million FDA fee waiver for drug application

March 17, 2026 8:30 AM EDT Send to a Friend
PolyPid Ltd. (NASDAQ: PYPD) announced that the U.S. Food and Drug Administration has granted a small business waiver of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login